Amgen
This laboratory-based role focuses on driving cutting-edge technology development in RNA Therapeutics and Genetic Medicines through cross-functional collaboration. The position involves utilizing biology and chemistry to advance innovation in oligonucleotide drug discovery and delivery to new cellular targets. The role aims to deliver on the promise of therapeutic modularity by enabling the delivery of molecules to specific outcomes.
Headquarters
Thousand Oaks, California, United States
Company Size
10001+ employees
Founded
1980
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Amgen.
57% above the average for this role
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained
1 day ago
Postdoctoral Fellow Position Available — RNA Therapeutics for Dermatological Diseases
UMass Chan Medical School
Senior Scientist, siRNA Pipeline Development, Ex-hepatic
AbbVie
Scientist of Synthetic Biology
Strand Therapeutics
Lead RNA Therapeutics Scientist
Wolf & Badger
Postdoctoral Fellow – Oligonucleotide Therapies, Streamlining design through omics dissection of mRNA biology
AstraZeneca
Lab Associate
Roche